Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Chromosomal microarray impacts clinical management

25 Jan 2013

Abstract excerpt

Chromosomal microarray analysis (CMA) is standard of care, first-tier clinical testing for detection of genomic copy number variation among patients with developmental disabilities. Although diagnostic yield is higher than traditional cytogenetic testing, management impact has not been well studied. We surveyed genetic services providers regarding CMA ordering practices and perceptions about reimbursement. Lack...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genomic variations and chromosomal abnormalities
Share to Genomics and Rare Diseases
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23347240
DOI: 10.1111/cge.12107

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Chromosomal microarray impacts clinical managementPMID 23347240Read ↗

The impact of chromosomal microarray on clinical management: a retrospective analysis.Semantic proximity Read ↗

Chromosomal Microarrays: Understanding Genetics of Neurodevelopmental Disorders and Congenital AnomaliesSemantic proximity Read ↗

Consensus Statement: Chromosomal Microarray Is a First-Tier Clinical Diagnostic Test for Individuals with Developmental Disabilities or Congenital AnomaliesSemantic proximity Read ↗

Physicians' perspectives on the uncertainties and implications of chromosomal microarray testing of children and familiesSemantic proximity Read ↗

Pathogenic or not? Assessing the clinical relevance of copy number variants.Semantic proximity Read ↗

Potentials and challenges of chromosomal microarray analysis in prenatal diagnosisSemantic proximity Read ↗

Chromosomal Microarray Analysis and Prenatal DiagnosisSemantic proximity Read ↗

Clinical impact of copy number variation analysis using high-resolution microarray technologies: advantages, limitations and concernsSemantic proximity Read ↗

Clinical Utility of Chromosomal Microarray AnalysisSemantic proximity Read ↗

Phenotypic signatures in clinical data enable systematic identification of patients for genetic testing.Semantic proximity Read ↗

Changing interpretation of chromosomal microarray over time in a community cohort with intellectual disability.Semantic proximity Read ↗

Genomic variation: what does it mean?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.